Unique ID issued by UMIN | C000000086 |
---|---|
Receipt number | R000000137 |
Scientific Title | A randomized controlled trial to compare surgical effectiveness of tumor enucleation versus systematic segmentectomy for resecting hepatocellular carcinoma |
Date of disclosure of the study information | 2005/11/01 |
Last modified on | 2021/04/09 14:21:26 |
A randomized controlled trial to compare surgical effectiveness of tumor enucleation versus systematic segmentectomy for resecting hepatocellular carcinoma
A randomized comparison of enucleation versus segmentectomy for hepatocellular carcinoma
A randomized controlled trial to compare surgical effectiveness of tumor enucleation versus systematic segmentectomy for resecting hepatocellular carcinoma
A randomized comparison of enucleation versus segmentectomy for hepatocellular carcinoma
Japan |
Cases with hepatocellular carcinoma scheduled to undergo hepatic resection.
Hepato-biliary-pancreatic surgery |
Malignancy
NO
To compare the disease-free survival after tumor enucleation or systematic segmentectomy for resecting hepatocellular carcinoma in a randomized controlled trial.
Safety,Efficacy
Confirmatory
Pragmatic
Phase III
Disease-free survival
Overall survival, disease-specific survival, postoperative complication
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Maneuver |
As an operative procedure, the patients are randomly assigned to undergo tumor enucleation for resecting hepatocellular carcinoma.
As an operative procedure, the patients are randomly assigned to undergo systematic segmentectomy for resecting hepatocellular carcinoma.
18 | years-old | <= |
80 | years-old | >= |
Male and Female
1. Clinically-proven hepatocellular carcinoma less than 50 mm in diameter. 2. Stage-1, 2, or 3 tumor in UICC-TNM classification. 3. Hepatic function of no ascites, total serum bilirubin value less than 1.0mg/dL, and indocyanine clearance rate less than 30%.
1. Recurrent hepatocellular carcinoma within 2 years after primary hepatic resection. 2. Multiple hepatocellular carcinoma. 3. Simultaneous other malignant disorders.
120
1st name | Tadatoshi |
Middle name | |
Last name | Takayama |
Nihon University School of Medicine
Department of Digestive Surgery
173-8610
30-1 Oyaguchikami-machi, Itabashi-ku, Tokyo 173-8610
03-3554-2345
takayama.tadatoshi@nihon-u.ac.jp
1st name | Tadatoshi |
Middle name | |
Last name | Takayama |
Nihon University School of Medicine
Department of Digestive Surgery
173-8610
30-1 Oyaguchikami-machi, Itabashi-ku, Tokyo 173-8610
03-3554-2345
takayama.tadatoshi@nihon-u.ac.jp
Department of Digestive Surgery, Nihon University School of Medicine
Foundation for Promotion of Cancer Research, Tokyo
Non profit foundation
Japan
Nihon University Itabashi Hospital, Surugadai Nihon University Hospital, Nihon University Nerima-Hikarigaoka Hospital
Ethics Committee of Nihon University School of Medicine
30-1 Oyaguchikami-machi, Itabashi-ku, Tokyo 173-8610
03-3972-8111
odagiri.hikaru@nihon-u.ac.jp
NO
日本大学医学部消化器外科(東京都)
2005 | Year | 11 | Month | 01 | Day |
Unpublished
2003 | Year | 03 | Month | 10 | Day |
2003 | Year | 04 | Month | 01 | Day |
2010 | Year | 12 | Month | 01 | Day |
2005 | Year | 08 | Month | 29 | Day |
2021 | Year | 04 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000137